Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study
Authors' conclusion
When the recommended dose of sugammadex was administered under qualitative NMM, residual NMB at the time of PACU arrival occurred frequently, indicating that quantitative NMM is necessary to ensure adequate recovery.
Study context
- Population
- Patients undergoing robot-assisted surgery under GA, March–May 2023
- Participants
- 51 patients
- Outcome
- Incidence of non-normalised train-of-four ratio (TOFR) (nTOFR) <0.9
- Follow-up
- Upon arrival in PACU
Main finding
As reported in the abstract
nTOFR <0.9 on PACU arrival
Incidence of nTOFR <0.9 on post-anaesthesia care unit (PACU) arrival
5.9%
3/51 patients
Observational data: associations, not effects.
Secondary outcomes
nTOFR <0.7 on PACU arrival · upon arrival in PACU
- No patient had a nTOFR <0.7
nTOFR <1.0 on PACU arrival · upon arrival in PACU
- Incidence of nTOFR <1.0
- 47.1% (24 patients)
Clinical symptoms/signs of residual neuromuscular blockade (NMB)
- No patients showed clinical symptoms/signs of residual NMB
Original publication
Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study. Anaesth Crit Care Pain Med. Published 16 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →